Viral profile of COPD exacerbations according to patients

Open Respiratory Medicine Journal

Volumn 9, Issue 1, 2014, Pages 1-8

  Dimopoulos, G ^a   Tsiodras, S ^a   Lerikou, M ^b   Chranioti, Aik ^a   Perros, E ^c   Anagnostopoulou, U ^b   Karakitsos, P ^a   Armaganidis, A ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Athens Chest Hospital   (Greece)

^c IASO GENERAL HOSPITAL   (Greece)

Author keywords

COPD exacerbations; Elderly; PCR; Viruses

Indexed keywords

ACINETOBACTER BAUMANNII; ADULT; AGED; ARTICLE; BACTERIUM ISOLATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; FEMALE; HAEMOPHILUS INFLUENZAE; HEART FAILURE; HOSPITALIZATION; HUMAN; HUMAN PARAINFLUENZA VIRUS 3; INFLUENZA; INFLUENZA VACCINATION; KIDNEY FAILURE; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MIXED INFECTION; NONHUMAN; PARAINFLUENZA VIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY VIRUS; SPIROMETRY; SPUTUM ANALYSIS; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; VIRUS INFECTION;

EID: 84928889783     PISSN: None     EISSN: 18743064     Source Type: Journal    
DOI: 10.2174/1874306401509010001     Document Type: Article

References (38)

1. Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis 2002; 2: 659-66.
2. Blot S, Cankurtaran M, Petrovic M, et al. Epidemiology and outcome of nosocomial bloodstream infection in elderly critically ill patients: A comparison between middle-aged, old, and very old patients. Crit Care Med 2009; 37(5): 1634-41.
3. Rooij S, Abu-Hanna A, Levi M, de Jonge E. Factors that predict outcome in intensive care treatment in very old patients: a review. Crit Care 2005; 9: R307-R314.
4. Sligl W, Eurich D, Marrie T, Majundar S. Age still matters: Prognosticating short-and long-term mortality for critically ill patients with pneumonia. Crit Care Med 2010; 38(11): 2126-32.
5. Mukherjee T, Pramod K, Srinivasan G, Rao MY. Nosocomial Infections in Geriatric Patients Admitted in ICU. J Indian Acad Geriatrics 2005; 2: 61-64.
6. Seemungal TA, Donaldson GC, Paul A. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1418-22.
7. Papi A, Bellettato CM, Braccioni F, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006; 173(10): 1114-21.
8. Sykes A, Mallia P, Johnston SL. Diagnosis of pathogens in exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007; 4(8): 642-6.
9. Henrickson KJ. Advances in laboratory diagnosis of viral respiratory disease. Pediatr Infect Dis J 2004; 23(1 Suppl): S6-10.
10. Dimopoulos G, Lerikou M, Tsiodras S, et al. Viral epidemiology of acute exacerbations of chronic obstructive pulmonary disease. Pulm Pharmacol Ther 2012; 25(1): 12-18.
11. World Health Organization. Health statistics and health information systems. Definition of an older or elderly person. Available at http: //www.who.int/healthinfo /survey/ageingdefnolder/ en/ index. html.
12. Sethi S. Infectious etiology of acute exacerbations of chronic bronchitis. Chest 2000; 117: 380-5S.
13. Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006; 24: 1159-69.
14. Targonski PV, Jacobson RM, Poland GA. Immunosenescence: role and measurement in influenza vaccine response among the elderly. Vaccine 2007; 25: 3066-9.
15. Burgel PR, Mannino D. Systemic inammation in patients with chronic obstructive pulmonary disease: one size no longer fits all. Am J Respir Crit Care Med 2012; 186: 936-7.
16. Calverley PM, Scott S. Is airway inammation in chronic obstructive pulmonary disease (COPD) a risk factor for cardiovascular events? COPD 2006; 3: 233-242.
17. Aw D, Silva AB, Palmer DB. Is the thymocyte development functional in the aged? Aging 2009; 1: 146-53.
18. Colonna-Romano G, Buffa S, Bulati M, et al. B cells compartment in centenarian offspring and old people. Curr Pharm Des 2010; 16: 604-8.
19. Dimopoulos G, Koulenti D, Blot S, et al. Elderly critically ill patients with infection: Analysis of the Extended Prevalence of Infection in Intensive Care Unit (EPIC II) Study. J Am Geriatr Soc 2013; 61(12): 2065-71.
20. Blot S, Cankurtaran M, Petrovic M, et al. Epidemiology and outcome of nosocomial bloodstream infection in elderly critically patients: a comparison between middle-aged, old, and very old patients. Crit Care Med 2009; 37(5): 1634-41.
21. Blot S, Vandewoude K, Hoste E, Poelaert J, Colardyn F. Outcome in critically ill patients with candida fungaemia: Candida albicans versus Candida glabrata. J Hosp Infect 2001; 47: 308-13.
22. Flevari A, Theodorakopoulou M, Velegraki A, Armaganidis A, Dimopoulos G. Treatment of invasive candidiasis in the elderly: a review. Clin Interv Aging 2013; 8: 1199-208.
23. Hof H, Mikus G. Candida infections in the elderly. Z Gerontol Geriatr 2013; 46: 64-70.
24. Baty F, Putora PM, Isenring B, Blum T, Brutsche M. Comorbidities and Burden of COPD: A Population Based Case-Control Study. PLoS One 2013; 8(5): e63285.
25. Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186: 155-161.
26. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012; 379: 1341-51.
27. Patel AR, Hurst JR. Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art. Expert Rev Respir Med 2011; 5: 647-662.
28. Vestbo J, Hurd SS, Agusti AG, et al. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease, GOLD Executive Summary. Am J Respir Crit Care Med 2013; 187: 347-65.
29. Masotti L, Ceccarelli E, Cappelli R, Barabesi L, Guerrini M, Forconi S. Length of hospitalization in elderly patients with community-acquired pneumonia. Aging (Milano) 2000; 12(1): 35-41.
30. Cydulka K, McFadden R, Emerman Jr, Sivinsky D, Pisanelli W, Rimm A. Patterns of hospitalization in elderly patients with asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156(6): 1807-12.
31. Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002; 347: 465-471.
32. Patel IS, Seemungal TA, Wilks M, et al. Relationship between bacterial colonization and the frequency, character, and severity of COPD exacerbations. Thorax 2002; 57: 759-764.
33. Nasreen S, Luby SP, Brooks WA, et al. Population-based incidence of severe acute respiratory virus infections among children aged < 5 years in rural Bangladesh, June-October 2010. PLoS One 2014; 9(2): e89978.
34. Earl ER, Quennec P, McDonald J. Infections due to parainfluenza virus type 4 in children. Clin Infect Dis 1993; 17(6): 998-1002.
35. Henrickson KJ. Parainfluenza viruses. Clin Microbiol Rev 2003; 16(2): 242-64.
36. Donaldson GC, Goldring JJ, Wedzicha JA. Influence of season on exacerbation characteristics in patients with COPD. Chest 2012; 141(1): 94-100.
37. Wilkinson TM, Donaldson GC, Johnston SL, Openshaw PJ, Wedzicha JA. Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173: 871-6.
38. Hayashi S. Latent adenovirus infection in COPD. Chest 2002; 121(5 Suppl): 183S-7.